The US Federal Trade Commission (FTC) has sued to block GTCR’s proposed $627m merger-acquisition of critical medical device coatings manufacturer Surmodics over anticompetitive activity concerns.

CHICAGO, Feb. 20, 2025 /PRNewswire/ -- GTCR, a leading private equity firm, announced the final close of Strategic Growth Fund II ("SGF II" or the "Fund") with approximately $3.6 billion in ...

Gifting allows recipients to access the article for free. Private-equity firm GTCR closed a $3.6 billion fund it will use for $50 million to $250 million investments in lower- and middle-market ...

GTCR announced its acquisition of Surmodics for $627 million GTCR invested in Biocoat, a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical ...

In the FTC’s first merger challenge of the new administration, the FTC voted 4-0 last week to challenge the proposed acquisition of Surmodics by private equity firm GTCR BC Holdings (“GTCR”).

Gifting allows recipients to access the article for free. The U.S. Federal Trade Commission has moved to block private-equity firm GTCR’s acquisition of Surmodics Inc., saying the deal would ...

The U.S. Federal Trade Commission (FTC) has moved to block the $627 million acquisition of cardiovascular devicemaker Surmodics by private equity firm GTCR over a potential plan to combine the ...

March 6 (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' (SRDX.O), opens new tab acquisition by private equity firm GTCR ...

Surmodics (NASDAQ:SRDX) fell 3.8% after the Federal Trade Commission filed a lawsuit to block its planned $627 million sale to private equity firm GTCR. The shares dropped 1.6% in after hours trading.

Additional Information About the Pending Acquisition of Surmodics by funds affiliated with GTCR On May 29, 2024, Surmodics announced it had entered into a definitive merger agreement to be ...

On March 6, 2025, the Federal Trade Commission (FTC) filed a lawsuit in federal court challenging GTCR BC Holdings, LLC's (GTCR) proposed acquisition of Surmodics, Inc. (Surmodics). The complaint ...

Surmodics, Inc. (NASDAQ:SRDX), a medical technology firm with a market capitalization of $424 million, is set to defend its planned merger with affiliates of GTCR LLC in court, following the U.S ...